Defense Agency Claims “Game-Changer” Virus Test

Pre-infectious test awaits FDA approval.

There are currently no known scientific cures for COVID-19, but scientists at the United States most advanced military agency have designed a test they say can identify people before they become infectious.

Described as a “game-changer,” the test came from a project at the Defense Advanced Research Projects Agency (DARPA), that was initially designed for diagnosing those who have become poisoned by germ or chemical warfare. It was repurposed for the coronavirus pandemic and may be able to detect the presence of the virus in as little as 24 hours after a person is infected.

The test looks at how a person’s body responds during its fight with the coronavirus, as opposed to just looking for the presence of the virus itself.

“The concept fills a diagnostic gap worldwide,” said the head of DARPA’s biological technologies office. If approved by the FDA for its emergency use, the test could be “absolutely a game-changer,” he said.

If approved, the U.S. could carry out as many as 1 million tests a day and could be “fully available” by early June. Currently, testing capacity in the U.S. is approximately 250,000 per day.

As the Lord Leads, Pray with Us…

  • For the potential that the new test developed by DARPA could have in identifying coronavirus infections at the earliest possible time.
  • For researchers in the U.S. and across the globe working on therapeutics and vaccines to stem the tide of the coronavirus.
  • For investigators who continue to look for the origins of the virus and how to prevent a recurrence.

Sources: The Guardian, Fox News


Back to top